Drug Trial Radar · NCT00202566
Efficacy and Safety of Ivabradine on Top of Atenolol in Stable Angina Pectoris
Last checked: Nov 19, 2026Latest source record: Mar 15, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
750
Planned (sponsor's estimate)
Start
Jun 2005
Primary completion
Not stated
Study completion Oct 2007
Sponsor
- Lead sponsor
- Institut de Recherches Internationales ServierAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Sep 20, 2005
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To test whether ivabradine when given in combination with atenolol is able to improve the exercise tolerance of patients with stable angina pectoris
Conditions
- Angina Pectoris
Interventions
IvabradineDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Improvement between baseline and end of treatment of the treadmill exercise tolerance test
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Montreal Heart Institute
Montreal, Quebec, Canada
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.